Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CASTLE: Clopidogrel Loading Dose in PCI
NCT00716924Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2004
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in coronary artery disease (CAD), sponsored by Sanofi. Started May 2004; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00716924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716924.